P2Y1 Receptor
P2RY1proteinP2Y1 receptor mediates ADP-dependent platelet activation and thrombus formation at the site of plaque rupture.
Pathway placement
Cascade stepPlatelet adhesion & activation
Confidencehigh
RationaleP2Y1 is a core platelet activation receptor mediating ADP-triggered adhesion and aggregation.
Druggability
DruggableYes
Known drugs / candidates2
Small-molecule tractableYes
Antibody tractableYes
EnsemblENSG00000169860
Type I vs Type II discrimination
ScoresLow-confidence (proxy)
R — rupture / Type-I61
C — confounder / Type-II45
A — assay feasibility72
E — evidence strength24
T1DI (composite)10
Specificity differential (R−C)+16.2
Confounder panel (Type-II drivers)
No confounder evidence retrieved.
Tier: light (literature co-occurrence proxy — lower confidence). See the discrimination table for all markers.
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)
Literature evidence(1)
- Abacavir causes leukocyte/platelet crosstalk by activating neutrophil P2X7 receptors thus releasing soluble lectin-like oxidized low-density lipoprotein receptor-1.British journal of pharmacology · 2023 · PMID 36541109 · doi